Gut bacteria linked to the development of inflammatory bowel disease

Dysbiosis in the gut microbiota is associated with the pathogenesis of inflammatory bowel disease (IBD).

• The incidence of inflammatory bowel disease (IBD) is increasing globally.
• IBD includes chronic conditions like ulcerative colitis and Crohn's disease.
• The etiology of IBD is not fully understood, involving genetics, environmental factors, and immune responses.
• The gut microbiota plays a role in nutrition, immune function, and host defense.
• Alterations in the gut microbiota composition, termed dysbiosis, have been identified in IBD patients.
• Therapeutic options to address dysbiosis include probiotics and fecal microbiota transplantation.

Simplified